| HOME | PRODUCTS & SERVICES | ORDER/INQUIRY | PRESS RELEASES | EMPLOYMENT | CONTACT US |
Volume 2, # 7/8 - November/December, 1996
Table of Contents
Current Treatment Modalities |
|
| Breast Cancer Staging and Prognosis | 410 |
| Standard Treatment by Stage | 410 |
| Carcinoma in situ | 412 |
| DICS | 412 |
| LCIS | 414 |
| Stage I Breast Cancer | 414 |
| Stage II Breast Cancer | 415 |
| Postoperative chest wall radiotherapy | 415 |
| Adjuvant combination chemotherapy | 415 |
| Node-Negative Breast Cancer | 419 |
| Stage IIIA (Operable) Breast Cancer | 419 |
| Stage IIIB (Inoperable) Breast Cancer | 419 |
| Stage IV Breast Cancer | 420 |
| Inflammatory Breast Cancer | 420 |
| Recurrent Breast Cancer | 420 |
| Breast Tumor HIstology | 420 |
| Staging by Hormonal Status | 420 |
| Surgery | 420 |
| Standard Surgical Interventions | 420 |
| Mastectomy | 420 |
| Lumpectomy | 423 |
| Novel Surgical Approaches | 423 |
| Interstitial laser photocoagulation | 423 |
| Cryosurgery | 423 |
| Ultrasound | 423 |
| Radiation Therapy | 423 |
| Adjuvant, Neoadjuvant, Salvage and Palliative Treatment Approaches | 424 |
| Hormonal Therapy | 425 |
| Antiestrogen Agents | 425 |
| Tamoxifen | 425 |
| Toremifine | 426 |
| Aromatase Inhibitors | 426 |
| Standard Cytotoxic Chemotherapy | 436 |
| Anthracyclines | 436 |
| Taxanes | 436 |
| High-Dose (Density Chemotherapy (HDC) | 437 |
| HDC with Hematopoietic Growth Factor Support | 437 |
| HDC with Hematopoietic Cell Transplantation | 438 |
| Autologous bone marrow transplant | 439 |
| Peripheral blood stem cell transplantation | 439 |
| Treatment of Complications of Breast Cancer | 440 |
| Hypercalcemia/Bone Pain Palliation | 440 |
| Pamidronate | 441 |
From the 19th Annual San Antonio Breast Cancer Symposium San Antonio, TX - December 12-14, 1996 |
|
| New Approaches in High Dose Chemotherapy For the Treatment of Breast Cancer | 442 |
| High-Dose Chemotherapy with Stem Cell Support | 442 |
| Tandem High-Dose Chemotherapy with Stem Cell Support | 443 |
| Factors Predicting Survival with High-Dose Chemotherapy | 443 |
| High-Dose Chemotherapy with Stem Cell Support in Non-metastatic Disease | 444 |
| HER-2/neu Overexpression and Relapse | 444 |
| New Agents and Novel Regimens for Endocrine Therapy in Breast Cancer | 445 |
| Estrogen Replacement Therapy | 445 |
| Tamoxifen in the Neo-adjuvant Setting | 445 |
| Aramatase Inhibitors | 445 |
| Anastrozole | 445 |
| Letrozole | 445 |
| Liarozole fumarate | 445 |
| Progesterone Receptor Antagonists | 446 |
| Onapristone | 446 |
| Combination Endocrine Therapies | 446 |
| Interferon-ß | 446 |
| Vinorelbine | 447 |
| Re-evaluation of Stabilized Disease Associated with Endocrine Therapy | 447 |
| Corrections | 447 |
| Introgen Therapeutics | 447 |
| Additions | 447 |
| More on Prostate Cancer | 447 |
| Bone Care International | 447 |